Iron deficiency is the most common cause of anemia in pregnancy. Pregnant women with anemia are, in general, exclusively treated with iron supplementation. We observed that several pregnant women with anemia who were nonresponsive to iron supplementation also had vitamin B6 deficiency, and that anemia in these cases improved with the administration of vitamin B6. Our prospective study in healthy pregnant women showed that blood levels of iron, ferritin and vitamin B6, in particular, fell to the lower limit of the nonpregnant reference range by the third trimester. We conclude that it is important to take into account the deficiency of vitamin B6 besides iron in the evaluation of anemia during pregnancy. 
Introduction
Anemia during pregnancy can be caused by various factors including loss of blood; shortage of iron, folate or vitamin B12; or underlying diseases such as hemoglobinopathies (for example, thalassemia and sickle cell disease), chronic inflammatory diseases, autoimmune disorders and malignancies. The World Health Organization (WHO) recommends that the hemoglobin (Hb) level should be maintained at or above 110 g/l during pregnancy (WHO, 1992) . Severe anemia may be associated with adverse effects on both the mother and the fetus. A study of a cohort of 629 pregnant women in Pakistan showed that the risk of preterm delivery and low birth weight was 4 and 1.9 times higher, respectively, in anemic women (Hb o110 g/l) than in pregnant women without anemia (Lone et al., 2004) . Iron deficiency is the most common cause of nutritional anemia in pregnancy (WHO, 1992) . As iron stores in the mother diminish during pregnancy due to the physiological increase in the red cell mass and additional demands of the fetus (Letsky, 2002) , adequate dietary iron intake and iron supplementation must be ensured in pregnant women. Therefore, pregnant women with anemia are generally treated with iron supplementation. Despite the known possibility of decreasing levels of other micronutrients (including vitamin B6) during pregnancy and causing or aggravating anemia, such nutrient supplementation is not appreciably popular.
This study indicates that vitamin B6 deficiency is one of the common causes of nutritional anemia in pregnancy. We conducted a prospective study of the variability of the serum levels of iron, ferritin, vitamin B6, vitamin B12, folate and total protein/albumin in healthy women during each trimester of pregnancy, and analyzed the clinical features of pregnant women with vitamin B6 deficiency.
Participants and methods
Between December 2002 and February 2008, we performed an analysis of 56 pregnant women with anemia who had evidence of vitamin B6 deficiency at the National Center for Child Health and Development (NCCHD), Tokyo. To examine the cause of anemia, the serum concentrations of vitamin B6 (as the sum of pyridoxal-5 0 -phosphate (PLP) and pyridoxal) were measured in these subjects, using a highperformance liquid chromatographic method (Ubbink et al., 1985) . We collected the following data from all subjects: history of iron supplementation, blood levels of total protein as an indicator of the nutritional status and obstetric background.
To assess the variability in the blood levels of nutrients associated with blood production during pregnancy, we conducted a prospective study from January 2007 through August 2008, at two locations in Japan (NCCHD, Tokyo and National Hospital Organization Fukushima Hospital, Fukushima). A total of 79 healthy pregnant volunteers in the first trimester were enrolled for this study. Subjects received no supplementation with iron, vitamin B6, vitamin B12 or folate throughout pregnancy. Serum levels of iron, ferritin, vitamin B6, vitamin B12, folate and total protein/albumin were measured in each trimester of pregnancy. Written informed consent was obtained from all subjects before the start of the study.
Results
Among the 56 anemic pregnant women with vitamin B6 deficiency, iron supplementation had already been begun in 24 women without confirmation of iron deficiency, with no improvement of anemia. The mean serum total protein was low (55.6 ± 4.1 g/l), with 82% of the women having concentrations lower than 60 g/l. A relatively high percentage of multiple pregnancies (32%) was also noted in the women with vitamin B6 deficiency. Table 1 shows five typical cases of vitamin B6 deficiency anemia. Although these subjects were nonresponsive to iron supplementation, anemia improved with vitamin B6 treatment (pyridoxine hydrochloride) with a daily dose of 75 mg.
In the prospective study of healthy pregnant women, reductions in the concentrations of all measured micronutrients were observed with advancing stage of gestation, with many deficiencies becoming significant during the third trimester (Figure 1) . The mean concentrations of iron, ferritin and vitamin B6 (as the sum of PLP and pyridoxal) in the third trimester were 7.8 ± 3.6 mmol/l, 6.1 ± 2.4 mg/l and 22.1±8.2 nmol/l, respectively. These values approximate the lower limits (dotted lines in Figure 1 ) of the respective nonpregnant reference ranges. In contrast, the blood levels of vitamin B12 and folate showed only a decreasing tendency during pregnancy, with the mean concentrations of both maintained within the normal range. The mean concentrations of total protein and albumin, as indicators of nutritional status, during the third trimester were 64.5±3.0 and 34.3 ± 2.4 g/l, respectively, remaining almost unchanged throughout the pregnancy.
Discussion
We showed that some pregnant women with anemia who were nonresponsive to iron supplementation had vitamin B6 deficiency, and that anemia in these women improved with the administration of vitamin B6. Although the women were successfully treated, for clinical judgment, it is important to clarify whether a low serum concentration of vitamin B6 reflects vitamin B6 deficiency or is a normal physiological response to pregnancy. To examine the nutrient status of healthy pregnant women, we prospectively examined the variability of serum concentrations of micronutrients influencing the production of erythropoietic cells, including iron, vitamin B6, vitamin B12, folate and total protein/albumin, with advancing stage of pregnancy. Although the blood levels of all micronutrients tended to decrease with advancing stage of pregnancy, in the third trimester the levels of iron and vitamin B6, in particular, fell to the lower limits of the nonpregnant reference range. These findings suggest that pregnant women are liable to develop vitamin B6 deficiency concurrently with iron deficiency. PLP, a reliable indicator of vitamin B6 nutritional status, is known to be hydrolyzed to pyridoxal by alkaline phosphatase (ALP). Vitamin B6 status during pregnancy may be affected by ALP, which is produced by the placenta. Barnard et al. (1987) indicate that accurate assessment of vitamin B6 nutritional status and a proper understanding of vitamin B6 physiology in pregnant women require measurement of both PLP and pyridoxal in plasma. Thus, in this study, we used the sum of PLP and pyridoxal in blood as markers of vitamin B6 status. It was recognized that our cases had obvious vitamin B6 deficiency by comparison to the nonpregnant reference range. 38  28  95  51  ND  99  116  DD twin  2  25  34  98  55  ND  99  117  3  31  31  90  52  ND  90  111  MD twin  4  28  31  97  55  ND  97  116  MD twin  5  35  17  96  53  15.5  96  115 Abbreviations: DD twin, dichorionic diamniotic twin; Hb, hemoglobin; MD twin, monochorionic diamniotic twin; ND, not detected; TP, total protein. The mean concentrations of total protein and albumin in the healthy pregnant women were maintained at approximately the initial levels throughout pregnancy, after accounting for the expansion of the plasma volume during pregnancy. In contrast, 82% of the women with vitamin B6 deficiency had low serum protein/albumin levels. Although this could reflect deficient nutrition caused by insufficient protein intake, we feel that reduced blood concentration of total protein is a characteristic feature of vitamin B6 deficiency in pregnant women. Furthermore, a high proportion of the women with vitamin B6 deficiency had had multiple pregnancies, which might act as a risk factor because of vitamin B6 accumulation by the fetus and placenta.
Vitamin B6 deficiency can preclude the initial enzymatic step of heme synthesis and the use of iron in erythropoietic cells (Institute of Medicine, 1998; Awad, 2006) . Deficiency of both iron and vitamin B6 causes microcytic hypochromic anemia and an indistinguishable blood picture, suggesting the necessity of measurement of concentrations of both, to make an appropriate diagnosis. In medical practice, iron supplementation is generally adopted in pregnant women before any measurements. Herein, we report that vitamin B6 deficiency is commonly encountered in pregnant women and presumably contributes to the high prevalence of anemia in pregnancy. Vitamin B6 deficiency and anemia in pregnancy M Hisano et al
